First-line treatment patterns among patients with metastatic pancreatic ductal adenocarcinoma in the real-world setting

被引:0
|
作者
Dennen, Syvart
Harton, Joanna
Cockrum, Paul
Kim, George P.
MacEwan, Joanna P.
机构
[1] Genesis Res Grp, Hoboken, NJ USA
[2] Ipsen Biopharmaceut Inc, Cambridge, MA USA
[3] Univ Florida, UF Hlth Canc Ctr, Gainesville, FL USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e16320
引用
收藏
页数:1
相关论文
共 50 条
  • [21] First-Line Treatment Outcomes of CML Patients in a Real-World Data Setting in Lebanon
    Nasr, Fadi
    Yehia, Intissar
    El Khoury, Reem
    Diab, Saada
    Al Ghoche, Ahmad
    Nasr, Lewis
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S332 - S333
  • [22] First-line systemic real-world treatment of patients with advanced/metastatic NSCLC in the UK
    Wang, M.
    Dhokia, P.
    Menon, S.
    Martindale, B.
    ANNALS OF ONCOLOGY, 2018, 29 : 22 - 22
  • [23] Updates on First-Line Treatment of Metastatic Pancreatic Adenocarcinoma
    Strimpakos, Alexios S.
    Syrigos, Kostas N.
    Saif, Muhammad Wasif
    JOURNAL OF THE PANCREAS, 2011, 12 (04): : 339 - 342
  • [24] Overall survival and treatment patterns among real-world patients with locally advanced or metastatic urothelial carcinoma treated with first-line therapy
    Simeone, Jason C.
    Nordstrom, Beth L.
    Patel, Ketan
    Klein, Alyssa B.
    Horne, Laura
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [25] Treatment patterns: Targeted therapies indicated for first-line management of metastatic renal cell carcinoma in a real-world setting.
    Hess, Gregory P.
    Borker, Rohit
    Fonseca, Eileen
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [26] Understanding real-world treatment patterns of patients with advanced ovarian cancer in the first-line maintenance setting: The FIRST STEP Study
    Cooney, Maureen
    Kalilani, Linda
    Kiss, Zsofia
    Golembesky, Amanda
    Kobayashi, Monica
    Dayma, Megha
    Coskuncay, Elif
    Schilder, Jeanne
    GYNECOLOGIC ONCOLOGY, 2024, 190 : S202 - S203
  • [27] Comparison of first-line (1L) treatment (tx) patterns and overall survival by age at diagnosis among patients with metastatic pancreatic ductal adenocarcinoma (mPDAC).
    Elias, Rawad
    Cockrum, Paul
    Surinach, Andy
    Wang, Shu
    Chu, Bong Chul
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
  • [28] Real-world overall survival and time to next treatment in patients with metastatic pancreatic ductal adenocarcinoma who received FOLFIRINOX and modified FOLFIRINOX in the first line.
    Dennen, Syvart
    Boppudi Naga, Sai Sriteja
    Cockrum, Paul
    Paluri, Ravi Kumar
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 629 - 629
  • [29] Real-World Treatment Patterns and Healthcare Costs Among Patients with FL with Early Treatment Failure of First-Line Chemoimmunotherapy
    Leslie, Lori A.
    Emond, Bruno
    Lafeuille, Marie-Helene
    Vermette-Laforme, Maude
    Lefebvre, Patrick
    Huang, Qing
    AMERICAN HEALTH AND DRUG BENEFITS, 2022, 15 (03): : 75 - 85
  • [30] Real-World Treatment Patterns and Economic Burden Following First-Line Trastuzumab in Patients with Metastatic Gastric Cancer in the USA
    Afsaneh Barzi
    Feng Lin
    Jinlin Song
    Clara Lam
    Xiaoyu Nie
    Ahmed Noman
    Winghan J. Kwong
    Drugs - Real World Outcomes, 2023, 10 : 395 - 404